|
⚲
|
| Synergy Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 001347613 |
| Sale | 2009-02-12 ($18.2 M Offered, $15.9 M Sold) |
| Fund | |
| Phone | 2122970020 |
| Address | 420 Lexington Avenue New York, 10170 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Melvin Spigelman | |
| Bernard Denoyer | |
| Kunwar Shailubhai | |
| John Brancaccio | |
| Thomas Adams | |
| Gary Jacob | |
| Gabriele Cerrone |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Hayward Deborah E
✚
|
0.0 | |
|
Avant Capital Management HK Limited
✚
|
0.0 | |
|
Smart-RIA Ventures, Inc.
✚
|
0.0 | |
|
Hayward Marshall A.
✚
|
0.0 | |
|
Hazard Control Technologies, Inc.
✚
|
0.0 | |
|
Hazelbrook Investors (Bermuda) L.P.
✚
|
0.0 | |
|
Hicks Robert J
✚
|
0.0 | |
|
Price Michael Dennis
✚
|
0.0 | |
|
Hicok Kyle
✚
|
0.0 | |
|
Hays Rick
✚
|
0.0 |